切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2023, Vol. 19 ›› Issue (03) : 261 -266. doi: 10.3877/cma.j.issn.1673-5250.2023.03.003

专题论坛

早产儿疫苗预防接种及时性
周美岑, 王华(), 母得志   
  1. 四川大学华西第二医院新生儿科、出生缺陷与相关妇儿疾病教育部重点实验室,成都 610041
  • 收稿日期:2022-11-30 修回日期:2023-04-05 出版日期:2023-06-01
  • 通信作者: 王华

Vaccination timeliness in preterm infants: a review of literature

Meicen Zhou, Hua Wang(), Dezhi Mu   

  1. Department of Pediatrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
  • Received:2022-11-30 Revised:2023-04-05 Published:2023-06-01
  • Corresponding author: Hua Wang
  • Supported by:
    Basic Research for Application Project of Science and Technology Department of Sichuan Province(2021YJ0171)
引用本文:

周美岑, 王华, 母得志. 早产儿疫苗预防接种及时性[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 261-266.

Meicen Zhou, Hua Wang, Dezhi Mu. Vaccination timeliness in preterm infants: a review of literature[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(03): 261-266.

早产儿一直是全球公共卫生关注的重点人群,对其进行疫苗预防接种具有重要意义。国内外早产儿均存在疫苗接种不及时的问题,早产儿自身条件、医务系统、家庭及产妇与社会因素,均可对早产儿按时进行疫苗预防接种产生影响。笔者拟就早产儿疫苗预防接种及时性、影响因素及解决策略的最新研究现状进行阐述,旨在提高早产儿疫苗预防接种的及时性。

Preterm infants have always been the key population of global public health concern, and their vaccination is of great significance. Premature infants at home and abroad are not vaccinated in time, which is influenced by their own conditions, medical system, family, maternal and social factors. In order to improve the timeliness of premature infant vaccine vaccination, the author intends to elaborate the current research situations, influencing factors and solving strategies of timeliness of premature infants vaccine vaccination.

[1]
Rayment-Jones H, Dalrymple K, Harris J, et al. Project20: does continuity of care and community-based antenatal care improve maternal and neonatal birth outcomes for women with social risk factors? A prospective, observational study[J]. PLoS One, 2021, 16(5): e0250947. DOI: 10.1371/journal.pone.0250947.
[2]
Deng K, Liang J, Mu Y, et al. Preterm births in China between 2012 and 2018: an observational study of more than 9 million women[J]. Lancet Glob Health, 2021, 9(9): e1226-e1241. DOI: 10.1016/S2214-109X(21)00298-9.
[3]
Nassir KF, Al-Saddi YI, Abbas HM, et al. Pentaglobin (immunoglobulin M-enriched immunoglobulin) as adjuvant therapy for premature and very low-birth-weight neonates with sepsis[J]. Indian J Pharmacol, 2021, 53(5): 364-370. DOI: 10.4103/ijp.ijp_881_20.
[4]
Soans S, Mihalyi A, Berlaimont V, et al. Vaccination in preterm and low birth weight infants in India[J]. Hum Vaccin Immunother, 2022, 18(1): 1-12. DOI: 10.1080/21645515.2020.1866950.
[5]
Tozzi AE, Piga S, Corchia C, et al. Timeliness of routine immunization in a population-based Italian cohort of very preterm infants: results of the ACTION follow-up project[J]. Vaccine, 2014, 32(7): 793-799. DOI: 10.1016/j.vaccine.2013.12.044.
[6]
Sioriki AA, Gkentzi D, Papadimitriou E, et al. Vaccinations in infants born preterm: an update[J]. Curr Pediatr Rev, 2020, 16(2): 148-155. DOI: 10.2174/1573396316666200116094459.
[7]
Guarnieri V, Giovannini M, Lodi L, et al. Severe pertussis disease in a paediatric population: the role of age, vaccination status and prematurity[J]. Acta Paediatr, 2022, 111(9): 1781-1787. DOI: 10.1111/apa.16436.
[8]
Bary-Weisberg D, Stein-Zamir C. Vaccination timeliness and completeness among preterm and low birthweight infants: a national cohort study[J]. Hum Vaccin Immunother, 2021, 17(6): 1666-1674. DOI: 10.1080/21645515.2020.1840255.
[9]
马超,安志杰,曾玫,等.《国家免疫规划疫苗儿童免疫程序及说明(2021年版)》要点解析[J]. 中国疫苗和免疫2021, 27(3): 235-241. DOI: 10.19914/j.cjvi.2021041.
[10]
Cho HK, Park SE, Kim YJ, et al. Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infants[J]. Clin Exp Pediatr, 2021, 64(12): 602-607. DOI: 10.3345/cep.2021.00507.
[11]
Badurdeen S, Marshall A, Daish H, et al. Safety and immunogenicity of early bacillus Calmette-Guérin vaccination in infants who are preterm and/or have low birth weights: a systematic review and Meta-analysis[J]. JAMA Pediatr, 2019, 173(1): 75-85. DOI: 10.1001/jamapediatrics.2018.4038.
[12]
宋渝丹,黎祺,黄勇,等. 中国特殊健康状态儿童疫苗接种研究进展[J]. 中国疫苗和免疫2022, 28(5): 595-600. DOI: 10.19914/j.CJVI.2022114.
[13]
Immunization in preterm and low birth weight infants[M]// Committee on Infectious Diseases, American Academy of Pediatrics; Kimberlin DW; Barnett ED; et al. Red book: 2021–2024 report of the committee on infectious diseases (32nd edition). American Academy of Pediatrics, 2021: 67-69.

URL    
[14]
Walker EJ, MacDonald NE, Islam N, et al. Completeness and timeliness of diphtheria-tetanus-pertussis, measles-mumps-rubella, and polio vaccines in young children with chronic health conditions: a systematic review[J]. Vaccine, 2019, 37(13): 1725-1735. DOI: 10.1016/j.vaccine.2019.02.031.
[15]
黄丽芳,周勇,吴瑞红,等. 福建省2017—2019年出生早产儿和低出生体重儿首剂乙型肝炎疫苗接种率和影响因素调查[J]. 中国疫苗和免疫2021, 27(3): 292-296. DOI: 10.19914/j.CJVI.2021054.
[16]
Qin W, Wang Y, Zhang X, et al. A retrospective study of hepatitis B vaccination in preterm birth and low birth weight infants born to hepatitis B surface antigen-positive mothers: Time to close the policy-practice gap[J]. Hum Vaccin Immunother, 2022, 18(7): 2155390. DOI: 10.1080/21645515.2022.2155390.
[17]
Jacobson EN, Hofstetter AM, Englund JA, et al. Early childhood vaccination status of preterm infants[J]. Pediatrics, 2019, 144(3): e20183520. DOI: 10.1542/peds.2018-3520.
[18]
Berbers GAM, Rouers EDM, Sanders EAM, et al. Timeliness of immunisations in preterm infants in the Netherlands[J]. Vaccine, 2019, 37(39): 5862-5867. DOI: 10.1016/j.vaccine.2019.08.006.
[19]
冯艳,吴长玉,王丽丽. 2015—2019年产科新生儿乙肝疫苗接种现状及对策探讨[J]. 临床医药文献电子杂志2020, 7(89): 167, 173.
[20]
古吉燕,王念蓉,何春燕,等. 0~6个月龄早产儿免疫规划疫苗接种情况分析[J]. 中国初级卫生保健2022, 36(3): 63-66, 71. DOI: 10.3969/j.issn.1001-568X.2022.03.0019.
[21]
李新海,温庆良,阮妹娇,等. 深圳市龙山社区儿童卡介苗接种率和及时接种率调查[J].预防医学情报杂志2021, 37(2): 265-270.
[22]
Choudhary TS, Reddy NS, Apte A, et al. Delayed vaccination and its predictors among children under 2 years in India: insights from the national family health survey-4[J]. Vaccine, 2019, 37(17): 2331-2339. DOI: 10.1016/j.vaccine.2019.03.039.
[23]
黄焕辉,韦日强. 2015—2018年河池市宜州区新生儿首针乙肝疫苗接种情况分析[J]. 中国当代医药2020, 27(13): 177-179..DOI: 10.3969/j.issn.1674-4721.2020.13.052.
[24]
师燕,朱一凡,刘海洋. 2018~2020年我院出生的新生儿乙肝疫苗首针接种情况的调查及影响因素分析[J]. 黑龙江医药科学2022, 45(5): 140-141, 143. DOI: 10.3969/j.issn.1008-0104.2022.05.060.
[25]
Gopal SH, Edwards KM, Creech B, et al. Variability in immunization practices for preterm infants[J]. Am J Perinatol, 2018, 35(14): 1394-1398. DOI: 10.1055/s-0038-1660453.
[26]
古吉燕,王念蓉,刘霞,等. 重庆市1 129名特殊健康状态儿童首针乙肝疫苗卡介苗迟种原因分析[J]. 公共卫生与预防医学2022, 33(3): 33-36. DOI: 10.3969/j.issn.1006-2483.2022.03.007.
[27]
雷妍. 城区孕妇乙型肝炎表面抗原携带率筛查和新生儿首剂乙肝疫苗及时接种保健工作现状分析[J]. 双足与保健2017, 26(20): 38-39. DOI: 10.19589/j.cnki.issn1004-6569.2017.20.038.
[28]
Nakatudde I, Rujumba J, Musoke P, et al. Vaccination timeliness and associated factors among preterm infants at a tertiary hospital in Uganda[J]. PLoS One, 2020, 14(9): e0221902. DOI: 10.1371/journal.pone.0221902.
[29]
王运媛,吴惠君,陈娇,等. 早产儿家长对卡介苗等免疫接种意愿状况及其影响因素分析[J]. 医学动物防制2020, 36(11): 1081-1084. DOI: 10.7629/yxdwfz202011016.
[30]
Di Mauro A, Di Mauro F, Greco C, et al. In-hospital and web-based intervention to counteract vaccine hesitancy in very preterm infants′ families: a NICU experience[J]. Ital J Pediatr, 2021, 47(1): 190. DOI: 10.1186/s13052-021-01129-x.
[31]
Chiappini E, Petrolini C, Caffarelli C, et al. Hexavalent vaccines in preterm infants: an update by Italian Society of Pediatric Allergy and Immunology jointly with the Italian Society of Neonatology[J]. Ital J Pediatr, 2019, 45(1): 145. DOI: 10.1186/s13052-019-0742-7.
[32]
Laforgia N, Di Mauro A, Bianchi FP, et al. Are pre-terms born timely and right immunized? Results of an Italian cohort study[J]. Hum Vaccin Immunother, 2018, 14(6): 1398-1402. DOI: 10.1080/21645515.2018.1428509.
[1] 张启龙, 柳亿, 卢会丽, 罗慧, 李成林, 王菁, 王辉. 奥妥珠单抗治疗磷脂酶A2受体相关膜性肾病的疗效与安全性:单中心回顾性分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 379-384.
[2] 陈桂华, 钟小玲, 谢雨, 王慧, 谢江, 杨涛毅. 合并肝脏疾病特殊健康状态儿童疫苗预防接种及时性临床分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 431-439.
[3] 王杰, 袁泉, 王玥琦, 乔佳君, 谭春丽, 夏仲元, 刘守尧. 溃疡油在糖尿病足溃疡治疗中的应用效果及安全性观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 480-484.
[4] 朴成林, 蓝炘, 司振铎, 李强, 冯健, 安峰铎, 冷建军. 胰十二指肠切除联合肝切除术疗效分析:附5例报告(附视频)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 363-367.
[5] 王浩源, 汪海洋, 孙建明, 陈以宽, 祁小桐, 唐博. 腹腔镜与开放修补对肝硬化腹外疝患者肝功能及凝血的影响[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 654-659.
[6] 韦雅丽, 范利杰. 术前右美托咪定滴鼻在腹股沟斜疝患儿腹腔镜下疝囊高位结扎术中的应用[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(04): 446-450.
[7] 黄建朋, 邹建强, 宗华. 肝移植术后腹壁疝诊治初步经验[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(04): 471-473.
[8] 王鹏, 邵欣欣, 胡海涛, 田艳涛, 钟宇新. 改良MOBS 吻合法在全腹腔镜近端胃大部分切除中的应用[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 267-270.
[9] 郭昆, 杨晓峰, 李传明. 双切口双钢板内固定治疗SchatzkerⅣ型以上复杂胫骨平台骨折的安全性及中远期预后的影响[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(03): 159-164.
[10] 陶金华, 陈珊珊, 陈晓四. 阿帕替尼联合替吉奥治疗晚期食管癌的疗效与安全性影响因素评价[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 325-329.
[11] 鲍乐, 刘颖, 王友彬, 陈龙, 朱玉芝, 梁爽, 权鹤太, 李鹏飞. 还阳通络灸在原发性肝癌介入治疗中的临床应用研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(03): 197-202.
[12] 谭莹, 朱鹏飞, 李楠, 黄莉吉, 周希乔, 严倩华, 余江毅. 火把花根片联合黄葵胶囊治疗高或极高进展风险糖尿病肾病的临床探索[J/OL]. 中华临床医师杂志(电子版), 2024, 18(02): 171-177.
[13] 李子健, 王锐, 钟云鹏, 张迪轩, 梁韵娟, 杨超, 何建行, 李树本. 自体肺移植术在胸部恶性肿瘤中的临床应用[J/OL]. 中华胸部外科电子杂志, 2024, 11(03): 193-200.
[14] 王平, 王艳秋, 乔辉, 高姣, 张凯利, 赵美淑. 胸腹腔灌注化疗序贯高频热疗在老年恶性胸腹腔积液患者中的应用效果[J/OL]. 中华老年病研究电子杂志, 2024, 11(02): 15-19.
[15] 颜宥彤, 赵锐, 万谦益, 张贵祥, 沈弘毅, 程中, 陈亿. GLP-1受体激动剂——司美格鲁肽的应用及安全性[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(02): 88-93.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?